Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (79) clinical trials

Northern California Research is enrolling participants for a Mild Dementia/Alzheimer's Disease study. The purpose of this study is to see if daily doses of a study medication will improve the symptoms of mild dementia due to Alzheimer's disease. This study medication has been designed to change the cortisol levels in ...

Phase

The purpose of this study is to evaluate Donepezil and Memantine for the treatment of Alzheimer's disease.

Phase

This study is a Phase 2, randomized, placebo controlled, dose ranging study of piromelatine (5, 20, and 50 mg daily for 6 months) versus placebo to determine an effective dose based on efficacy (cognitive performance), safety and tolerability in patients with mild dementia due to AD.

Phase

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Phase

Are you or someone you care for experiencing memory loss possibly due to Alzheimer's disease?

Phase

Alzheimer's disease is the most common neurodegenerative disorder and its prevalence steeply increases. The small number of effective treatments for Alzheimer's disease highlights a need for further research into novel therapeutic possibilities. Glutamate-mediated excitotoxicity in neuropsychiatric disorders and in particular in Alzheimer's disease has been shown to cause significant cerebral ...

Phase

Patient Inclusion Criteria: Ages: over 60 Male/Female 18 week long Clinical Trial Patient may not be full time permanent resident of nursing home Clinical diagnosis of probable AD with supportive brain imaging documentation Have existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 90 week Long Clinical Trial MMSE score 22-30 Positive amyloid load as indicated by PET assessment Age between 50 and 90 years, inclusive MMSE score equal to or greater than 22, and equal to or less than 30, at Screening and Baseline BMI ...

Phase